Inflammation in NAFLD/NASH is regulated by the NF-κB signaling cascade, which can activate the transcription of genes encoding pro-inflammatory enzymes and mediators, such as iNOS, cytokines, and chemokines [4,9,30,41]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.